Impact of Retrograde Autologous Priming on the Coagulation Profile Assessed by Rotation Thromboelastometry (ROTEM) in Patients Undergoing Cardiac Surgery
Status
Conditions
Treatments
Details and patient eligibility
About
Cardiac surgery with cardiopulmonary bypass (CPB) is associated with an increased risk of blood transfusions. The primary setup of the CPB circuit demands a priming volume of approximately 1600 mL of crystalloid solution which leads to a relevant hemodilution. The retrograde autologous priming (RAP) procedure minimizes hemodilution by displacing the crystalloid priming volume of arterial and venous lines via passive exsanguination of native blood prior to CPB initiation, resulting in higher hematocrits and reduction of red blood cell transfusion. RAP can also minimize the dilution of coagulation factors as well as red blood cells. Thus, the investigators hypothesized that RAP could maintain better coagulatory function after CPB. In this study, the investigators investigate the impact of RAP on the coagulation profile assessed by rotation thromboelastometry (ROTEM) in participants undergoing cardiac surgery.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients over 20 years of age undergoing cardiac surgery / vascular surgery using CPB
Exclusion criteria
- Emergency operation
- Hemoglobin concentration above 15g/dL
- Anticoagulants such as warfarin within 5 days before surgery, non-vitamin K antagonist oral
- anticoagulant within 2 days, and aspirin / clopidogrel / ticagrelor within 5 days
- Weight less than 45kg, more than 90kg
- Patients with autoimmune disease
- Patients who participated in other clinical studies that could affect prognosis
- Patients who cannot understand the informed consent (eg. Foreigner)
Trial design
Primary purpose
Allocation
Interventional model
Masking
104 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal